ANGO Insider Trading Activity and SEC Form 4 Filings
ANGO insider trading summary
Over the past 12 months, insiders at Angiodynamics Inc (ANGO) reported 2 sales worth $311K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $311K.
Latest ANGO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 29, 2026 | Stephen A Trowbridge | EVP and CFO | Sell | $290K (23,615 @ $12.27) |
| Oct 28, 2026 | Stephen A Trowbridge | EVP and CFO | Sell | $21K (1,720 @ $12.17) |
| Oct 21, 2025 | Lawrence T Weiss | SVP, Chief Legal Officer | Buy | $118K (10,000 @ $11.81) |
| Oct 13, 2025 | Stephen A Trowbridge | EVP and CFO | Buy | $10K (890 @ $11.16) |
| Oct 9, 2025 | James C Clemmer | President and CEO | Buy | $112K (10,000 @ $11.15) |
| Jan 16, 2025 | Warren Nighan JR | SVP Quality and Regulatory | Sell | $50K (4,060 @ $12.31) |
| Oct 10, 2024 | Warren Nighan JR | SVP Quality and Regulatory | Buy | $608 (100 @ $6.08) |
| Oct 8, 2024 | Stephen A Trowbridge | EVP and CFO | Buy | $10K (1,700 @ $5.86) |
| Oct 7, 2024 | Warren Nighan JR | SVP Quality and Regulatory | Buy | $5K (768 @ $6.09) |
| Oct 7, 2024 | James C Clemmer | President and CEO | Buy | $121K (20,000 @ $6.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.